Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,765 | 20,175 | 27,749 | 14,232 | 6,939 |
| TOTAL | $59,898 | $21,617 | $28,144 | $14,509 | $7,506 |
| Non-Current Assets | |||||
| PPE Net | 97 | 110 | 124 | 694 | 152 |
| Other Non-Current Assets | 1,244 | 1,003 | 43 | 3,429 | 0 |
| TOTAL | $1,341 | $1,113 | $167 | $4,123 | $152 |
| Total Assets | $61,239 | $22,730 | $28,311 | $18,632 | $7,658 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,240 | 1,513 | 2,567 | 1,627 | 1,569 |
| Accrued Expenses | 1,019 | 898 | 866 | 6,030 | 343 |
| TOTAL | $2,259 | $2,411 | $3,433 | $12,638 | $1,912 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 3,912 | 10,515 |
| TOTAL | $N/A | $N/A | $N/A | $3,912 | $10,515 |
| Total Liabilities | $2,259 | $2,411 | $3,433 | $16,550 | $12,427 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 540 | 513 | 448 | 64 | 64 |
| Common Shares | 13 | 11 | 11 | 23 | 2 |
| Retained earnings | -51,457 | -46,881 | -41,781 | -289,680 | -4,970 |
| TOTAL | $58,980 | $20,319 | $24,878 | $2,082 | $-4,769 |
| Total Liabilities And Equity | $61,239 | $22,730 | $28,311 | $18,632 | $7,658 |